Laser Photonics Launches R&D Initiative to Accelerate Innovation
Laser Photonics (NASDAQ: LASE) has launched a research and development initiative focusing on industrial laser solutions for pharmaceutical tablet drilling, wafer scribing, and semiconductor marking. Following the acquisition of Control Micro Systems (CMS), the company is investing resources to advance newly acquired laser systems. The initiative targets three main sectors: pharmaceuticals (tablet drilling and marking system for time-release medications), wafers (serialization system for wafers up to 300mm wide), and semiconductors (marking system with UV laser and galvanometer scanhead). These developments aim to expand LPC's market presence in diversified industries.
Laser Photonics (NASDAQ: LASE) ha lanciato un iniziativa di ricerca e sviluppo incentrata su soluzioni laser industriali per la perforazione di compresse farmaceutiche, la scribing di wafer e la marcatura di semiconduttori. Dopo l'acquisizione di Control Micro Systems (CMS), l'azienda sta investendo risorse per sviluppare i nuovi sistemi laser acquisiti. L'iniziativa si rivolge a tre settori principali: farmaceutici (sistema di perforazione e marcatura per farmaci a rilascio controllato), wafer (sistema di serializzazione per wafer fino a 300 mm di larghezza) e semiconduttori (sistema di marcatura con laser UV e testina di scansione a galvano). Questi sviluppi mirano ad ampliare la presenza di LPC nel mercato di settori diversificati.
Laser Photonics (NASDAQ: LASE) ha lanzado una iniciativa de investigación y desarrollo centrada en soluciones láser industriales para la perforación de tabletas farmacéuticas, la separación de obleas y la marcación de semiconductores. Tras la adquisición de Control Micro Systems (CMS), la empresa está invirtiendo recursos para avanzar en los nuevos sistemas láser adquiridos. La iniciativa tiene como objetivo tres sectores principales: farmacéuticos (sistema de perforación y marcación para medicamentos de liberación controlada), obleas (sistema de serialización para obleas de hasta 300 mm de ancho) y semiconductores (sistema de marcación con láser UV y cabezal de escaneo de galvánico). Estos desarrollos buscan expandir la presencia de LPC en el mercado de sectoresDiversos.
레이저 포토닉스 (NASDAQ: LASE)는 제약 약물의 구멍 뚫기, 웨이퍼 스크라이빙 및 반도체 마킹을 위한 산업 레이저 솔루션에 중점을 둔 연구 및 개발 이니셔티브를 출시했습니다. Control Micro Systems (CMS)를 인수한 후, 회사는 새로 인수한 레이저 시스템을 발전시키기 위해 자원을 투자하고 있습니다. 이 이니셔티브는 세 가지 주요 분야를 목표로 하고 있습니다: 제약 (적시 방출 약물을 위한 구멍 뚫기 및 마킹 시스템), 웨이퍼 (최대 300mm 너비의 웨이퍼를 위한 직렬화 시스템), 및 반도체 (UV 레이저 및 갈바노미터 스캔 헤드가 있는 마킹 시스템). 이러한 개발은 다양한 산업에서 LPC의 시장 존재를 확장하는 것을 목표로 하고 있습니다.
Laser Photonics (NASDAQ: LASE) a lancé une initiative de recherche et développement axée sur des solutions laser industrielles pour le perçage de comprimés pharmaceutiques, le scribing de wafers et le marquage de semi-conducteurs. Suite à l'acquisition de Control Micro Systems (CMS), l'entreprise investit des ressources pour faire progresser les systèmes laser nouvellement acquis. L'initiative cible trois secteurs principaux : pharmaceutiques (système de perçage et de marquage pour médicaments à libération contrôlée), wafers (système de sérialisation pour les wafers allant jusqu'à 300 mm de large) et semi-conducteurs (système de marquage avec laser UV et tête de scan galvanométrique). Ces développements visent à étendre la présence de LPC sur le marché dans des secteurs diversifiés.
Laser Photonics (NASDAQ: LASE) hat eine Forschungs- und Entwicklungsinitiative ins Leben gerufen, die sich auf industrielle Laserlösungen für die Perforation von pharmazeutischen Tabletten, das Scribing von Wafern und die Markierung von Halbleitern konzentriert. Nach der Übernahme von Control Micro Systems (CMS) investiert das Unternehmen Ressourcen, um die neu übernommenen Lasersysteme weiterzuentwickeln. Die Initiative richtet sich an drei Hauptsektoren: Pharmazeutika (Perforations- und Markierungssystem für zeitgesteuerte Medikamente), Wafer (Serielles System für Wafer mit einer Breite von bis zu 300 mm) und Halbleiter (Markierungssystem mit UV-Laser und Galvanometer-Scanhead). Diese Entwicklungen sollen die Marktpräsenz von LPC in diversifizierten Branchen erweitern.
- Strategic acquisition of Control Micro Systems expands technological capabilities
- Entry into new high-value markets: pharmaceuticals, wafers, and semiconductors
- Development of advanced laser systems for multiple industrial applications
- R&D investments may increase operational expenses in the short term
Insights
The R&D initiative represents an incremental step in Laser Photonics' market expansion strategy following the Control Micro Systems acquisition, but lacks immediate financial impact metrics. While targeting pharmaceutical tablet drilling, wafer scribing and semiconductor marking shows strategic diversification, the announcement is primarily forward-looking without concrete revenue projections or development timelines.
The initiative focuses on three promising sectors:
- Pharmaceutical anti-counterfeiting solutions
- Wafer processing for electronics and solar applications
- Semiconductor marking systems
Following LPC’s recent acquisition of Control Micro Systems, Inc., the company is dedicating resources to a number of new engineering projects to continue advancing its newly acquired laser systems. This investment of time and expertise, leveraging the innovative technologies and know-how from Control Micro Systems (“CMS”), aims to expand LPC’s footprint in diversified markets.
“Laser technology has reformed material processing across numerous industries,” said Wayne Tupuola, CEO of LPC. “We’re now tapping into more of these market segments with the addition of Control Micro Systems. Its state-of-the-art technology and
New sectors of focus are pharmaceuticals, wafers, and semiconductors. Through the R&D initiative the company will be devoting additional resources to advance its currently available technology to maintain a competitive edge and meet the needs of the market. In the pharmaceutical space, LPC will further develop Control Micro Systems tablet drilling and marking system for time-release medications. This Class I automated CO2 laser system features a custom tablet fixture, fume extraction, and machine vision inspection for quality control, engineered as an anti-counterfeiting solution.
Laser technology for wafer serialization entails the marking, scribing, and lapping of wafers composed of silicon and related compounds. LPC will continue to advance Control Micro Systems multi-station system, which is tailored for wafers up to 300 mm wide and 300 – 800 microns in thickness and features robotic wafer positioning. This technology serves to facilitate the production and tracking of wafers for consumer electronics, solar panels, LEDs, MEMS devices, optoelectronic components, and others.
The third system LPC will continue advancing through this initiative is the semiconductor laser marking system by CMS. This system is engineered with a high-precision ultraviolet laser and a galvanometer scanhead, enabling fast fiducial recognition. This innovative technology produces small permanent markings on IC mold compounds and ceramics with minimal heat, ensuring no damage to the part. Machine vision aids in the verification of chip positioning and marking alignment.
Stay tuned for LPC’s forthcoming announcements, where the company will reveal more details about each system.
About Laser Photonics Corporation
Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and systems. Laser Photonics seeks to disrupt the
Cautionary Note Concerning Forward-Looking Statements
This press release contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company’s plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption “Risk Factors” in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241129227536/en/
Karla Kizzort
Marketing Specialist
Laser Photonics Corporation
kkizzort@laserphotonics.com
Source: Laser Photonics Corporation
FAQ
What new markets is Laser Photonics (LASE) targeting with its R&D initiative?
What capabilities did Laser Photonics (LASE) gain from the Control Micro Systems acquisition?